<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>FISH vs OGM comparison &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/fish-vs-ogm-comparison/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 03 Nov 2025 09:35:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>FISH vs OGM comparison &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Optical Genome Mapping Enhances CLL Diagnosis</title>
		<link>https://bioengineer.org/optical-genome-mapping-enhances-cll-diagnosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 03 Nov 2025 09:35:36 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CLL diagnosis]]></category>
		<category><![CDATA[FISH vs OGM comparison]]></category>
		<category><![CDATA[Genomic profiling in leukemia]]></category>
		<category><![CDATA[Optical genome mapping]]></category>
		<category><![CDATA[Structural variants and copy number variations]]></category>
		<guid isPermaLink="false">https://bioengineer.org/optical-genome-mapping-enhances-cll-diagnosis/</guid>

					<description><![CDATA[In a groundbreaking study poised to advance the diagnostic landscape of chronic lymphocytic leukemia (CLL), researchers have piloted the application of optical genome mapping (OGM) to complement traditional fluorescence in situ hybridization (FISH) analysis. Chronic lymphocytic leukemia, characterized by its clinical heterogeneity, has long challenged clinicians due to the complex genomic alterations that underpin its [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">290334</post-id>	</item>
	</channel>
</rss>
